Anzenna is a New York based life science diagnostics company, developing a disruptive transistor based biosensor to detect biological binding reactions for disease detection. Leveraging the semiconductor industry’s manufacturing infrastructure, Anzenna plans to provide an integrated diagnostic device capable of performing multiple tests simultaneously with label-free simplicity and speed at a fraction of the.